SCHEMBL1100103

SCHEMBL1100103

O=S(=O)(Nc1ccc(S(=O)(=O)N(CCC2CC2)c2sc3ccccc3c2Cl)cc1)C1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.35
BRD4 O60885 2/20 0.33
MCL1 Q07820 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
HDAC4 P56524 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
RORC P51449 1/20 0.31
PRSS12 P56730 1/20 0.31
MAPT P10636 2/20 0.31
PRMT6 Q96LA8 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PRNP P04156 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098639 0.90 KEAP1 (0.44) TRPM8KEAP1NFE2L2NPC1RAB9A
SCHEMBL1099707 0.89 HDAC4 (0.34) TRPM8BRD4KEAP1NFE2L2HDAC4
SCHEMBL1099266 0.87 TRPM8 (0.36) TRPM8KEAP1NFE2L2NPC1RAB9A
SCHEMBL1098203 0.83 KEAP1 (0.50) TRPM8KEAP1NFE2L2HTR1ADRD2
SCHEMBL1101372 0.82 TRPM8 (0.49) TRPM8KMT2A
SCHEMBL1097666 0.79 CYP3A4 (0.34) TRPM8NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL1099139 0.78 KEAP1 (0.44) TRPM8KEAP1NFE2L2HTR1ADRD2
SCHEMBL1100533 0.77 TRPM8 (0.33) TRPM8HTR1ADRD2HTR2A
SCHEMBL1098213 0.76 TRPM8 (0.34) TRPM8KEAP1NFE2L2HTR1ADRD2
SCHEMBL1099893 0.75 TRPM8 (0.44) TRPM8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885BRD4 960/4885MCL1 3803/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885BRD4 960/4885MCL1 3803/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885BRD4 960/4885MCL1 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.